These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8385779)
1. PAF-induced death in NMRI mice--a suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances. Becker K; Lueddeckens G; Grupe R; Förster W Prostaglandins Leukot Essent Fatty Acids; 1993 Mar; 48(3):265-71. PubMed ID: 8385779 [TBL] [Abstract][Full Text] [Related]
2. Role of platelet-activating factor (PAF) in the ovoimplantation in the rat: effect of the specific PAF-acether antagonist, BN 52021. Acker G; Hecquet F; Etienne A; Braquet P; Mencia-Huerta JM Prostaglandins; 1988 Feb; 35(2):233-41. PubMed ID: 3129758 [TBL] [Abstract][Full Text] [Related]
3. Influence of inhibitors of the eicosanoid metabolism, and of eicosanoids- and PAF-acether antagonists on mortality and some biochemical parameters of three shock models. Bahr T; Schaper U; Becker K; Lueddeckens G; Förster W; Scheuch DW; Grupe R Prog Clin Biol Res; 1989; 301():229-33. PubMed ID: 2798447 [No Abstract] [Full Text] [Related]
4. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286 [TBL] [Abstract][Full Text] [Related]
5. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia. László F; Whittle BJ; Moncada S Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265 [TBL] [Abstract][Full Text] [Related]
6. Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor. Filep JG; Hermán F; Földes-Filep E; Schneider F; Braquet P Br J Pharmacol; 1992 Apr; 105(4):912-8. PubMed ID: 1324056 [TBL] [Abstract][Full Text] [Related]
7. Role of PAF in the allergic pleurisy caused by ovalbumin in actively sensitized rats. Martins MA; Castro Faria Neto HC; Bozza PT; e Silva PM; Lima MC; Cordeiro RS; Vargaftig BB J Leukoc Biol; 1993 Jan; 53(1):104-11. PubMed ID: 8381149 [TBL] [Abstract][Full Text] [Related]
8. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists. Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798 [TBL] [Abstract][Full Text] [Related]
9. Influence of inhibitors of the eicosanoid metabolism, of antagonists of the eicosanoids and of PAF on mortality assayed in three biochemically characterized shock models. Bahr T; Schaper U; Becker K; Lueddeckens G; Förster W; Scheuch DW; Grupe R; Göres E Biomed Biochim Acta; 1988; 47(10-11):S289-92. PubMed ID: 3150272 [TBL] [Abstract][Full Text] [Related]
10. Relationships between tumour necrosis factor, eicosanoids and platelet-activating factor as mediators of endotoxin-induced shock in mice. Myers AK; Robey JW; Price RM Br J Pharmacol; 1990 Mar; 99(3):499-502. PubMed ID: 2110016 [TBL] [Abstract][Full Text] [Related]
11. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed. Dembinska-Kiec A; Peskar BA; Muller MK; Peskar BM Prostaglandins; 1989 Jan; 37(1):69-91. PubMed ID: 2717778 [TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3. Hostettler ME; Knapp PE; Carlson SL Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060 [TBL] [Abstract][Full Text] [Related]
14. [The effect of platelet-activating factor and its antagonist--BN 52021--on immune reactions in vivo in mice and in vitro]. Poveshchenko AF; Kozlov VA Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):53-6. PubMed ID: 10852052 [TBL] [Abstract][Full Text] [Related]
15. Influence of aminophylline and ketotifen in comparison to the lipoxygenase inhibitors NDGA and esculetin and the PAF antagonists WEB 2170 [correction of 2107] and BN 52021 on endothelin-1 induced vaso- and bronchoconstriction. Lueddeckens G; Becker K; Rappold R; Förster W Prostaglandins Leukot Essent Fatty Acids; 1991 Nov; 44(3):155-8. PubMed ID: 1808625 [TBL] [Abstract][Full Text] [Related]
16. Effects of platelet activating factor antagonists on arachidonic acid-induced platelet aggregation and TXA2 formation. Heinroth-Hoffmann I; Hauser A; Mest HJ Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):181-2. PubMed ID: 2149184 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure. Lopes-Martins R; Catelli M; Araújo C; Estato V; Cordeiro R; Tibiriçá E Eur J Pharmacol; 1996 Jul; 308(3):287-94. PubMed ID: 8858301 [TBL] [Abstract][Full Text] [Related]
18. Effect of platelet-activating factor on porcine pulmonary blood vessels in vitro. Pritze S; Simmet T; Peskar BA Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):495-9. PubMed ID: 1766475 [TBL] [Abstract][Full Text] [Related]
19. Species-dependent differences of high affinity [3H]PAF-binding to platelets from humans and pigs and its inhibition by selected antagonists. Ostermann G; Lorenz A; Hofmann B; Kertscher HP J Lipid Mediat; 1991 Nov; 4(3):289-98. PubMed ID: 1662546 [TBL] [Abstract][Full Text] [Related]